Multiple sclerosis (MS) is characterized by chronic inflammation ... Current treatment guidelines recommend starting disease-modifying therapies soon after disease onset. These treatments have ...

Leerink Partners analyst Faisal Khurshid reiterated a Buy rating on Immunic (IMUX – Research Report) on November 7 and set a price target ...

Opens in a new tab or window The quest to understand and slow disease progression in multiple sclerosis (MS) continued in ...

Shares of the company rose about 1% at $185.20 in premarket trading. The drugmaker has slashed jobs and pulled the plug on ...

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in ...

Medication and cognitive behavioral therapy can both help fight MS-related fatigue. A person’s sleep habits did play a role.

The researchers observed an increase in OOP costs for multiple sclerosis medications, by an average of 217%. (HealthDay News) — Generic medications reduce the out-of-pocket (OOP) costs for ...

With Children” and also from the “Anchorman” movies, has offered new insights in what it’s like to deal with multiple ...

Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all ...